Vertex Pharmaceuticals PEG Ratio

Vertex Pharmaceuticals's peg ratio stands at 453.15. That is above the Healthcare sector average of 3.22. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Vertex Pharmaceuticals sits higher the Healthcare benchmark (3.22) with a PEG ratio of 453.15. That is roughly 13961.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 453.15 is attractive depends on Vertex Pharmaceuticals's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Vertex Pharmaceuticals's PEG ratio evolved across reporting periods, while the comparison chart places VRTX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, PEG ratio is commonly used to spot outliers. Vertex Pharmaceuticals's reading of 453.15 (sector avg 3.22) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.